☰

Meredith B. Long, Ph.D. - Publications

Affiliations: 
2001 Duke University, Durham, NC 
Area:
Molecular Biology, Medicine and Surgery
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Long SB, Long MB, White RR, Sullenger BA. Crystal structure of an RNA aptamer bound to thrombin. Rna (New York, N.Y.). 14: 2504-12. PMID 18971322 DOI: 10.1261/Rna.1239308  0.571
2004 Kierlin MN, Byun J, Lan N, Long M, Sullenger B. 903. Group I Ribozymes and SMaRT|[trade]| as Trans-Splicing RNA Repair Therapies for |[beta]|-Globin Mutations Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.809  0.626
2003 Byun J, Lan N, Long M, Sullenger BA. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes. Rna (New York, N.Y.). 9: 1254-63. PMID 13130139 DOI: 10.1261/Rna.5450203  0.62
2003 Long MB, Jones JP, Sullenger BA, Byun J. Ribozyme-mediated revision of RNA and DNA. The Journal of Clinical Investigation. 112: 312-8. PMID 12897196 DOI: 10.1172/Jci19386  0.651
2000 Guo H, Karberg M, Long M, Jones JP, Sullenger B, Lambowitz AM. Group II introns designed to insert into therapeutically relevant DNA target sites in human cells. Science (New York, N.Y.). 289: 452-7. PMID 10903206 DOI: 10.1126/Science.289.5478.452  0.579
1999 Long MB, Sullenger BA. Evaluating group I intron catalytic efficiency in mammalian cells. Molecular and Cellular Biology. 19: 6479-87. PMID 10490588 DOI: 10.1128/Mcb.19.10.6479  0.625
Show low-probability matches.